|
1MKE
Structure of the N-WASP EVH1 Domain-WIP complex
Deposited 2002-08-29
|
Different construct
Different oligomeric state
Different experimental conditions
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
461–485(25 aa)
Fragment:WIP peptide and N-WASP EVH1 domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;303 K;Ionic strength (raw mmCIF value) 20 mM NaCl;Pressure ambient
NMR sample composition
U-15N protein
20 mM PO4 buffer
1 mM dithiothreitol | 90% H2O/10% D2O
NMR sample composition
U-13C/15N protein
20 mM PO4 buffer
1 mM dithiothreitol | 90% H2O/10% D2O
|
Resolution not provided
|
|
2A41
Ternary complex of the WH2 Domain of WIP with Actin-DNAse I
Deposited 2005-06-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
29–60(32 aa)
Fragment:first WH2 domain
|
Not recorded
|
CA CALCIUM ION × 2
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
FMT FORMIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;sodium formate, PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.60 Å
R-free 0.219
|
|
2IFS
Structure of the N-WASP EVH1 domain in complex with an extended WIP peptide
Deposited 2006-09-21
|
Different construct
Different oligomeric state
Different experimental conditions
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
451–485(35 aa)
Fragment:WIP peptide (residues 451-485) and N-WASP EVH1 domain (Residues 26-147)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;303 K;Ionic strength (raw mmCIF value) 0.044 mM;Pressure 1
NMR sample composition
1.0 mM U-15N/13C protein, 20 mM sodium phosphate, 1 mM Dithiothreitol, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
9EZO
Canonical class 2 structure of the human cortactin SH3 domain in complex with WIP-derived peptide
Deposited 2024-04-13
|
Different experimental conditions
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
165–183(19 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.6;298 K;Ionic strength (raw mmCIF value) 0.055;Pressure 1
NMR sample composition
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR sample composition
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 100% D2O | 100% D2O
NMR sample composition
0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 1.1 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 1 mM dithiothreitol, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR sample composition
0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 1.1 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 1 mM dithiothreitol, 100% D2O | 100% D2O
NMR sample composition
0.22 mM [U-99% 13C; U-99% 15N] Human cortactin SH3 domain (494-550), 1.1 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 1 mM dithiothreitol, 100% D2O | 100% D2O
|
Resolution not provided
|
|
9EZP
Non-canonical structure of the human cortactin SH3 domain in complex with WIP-derived peptide
Deposited 2024-04-13
|
Parsed fields agree
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
165–183(19 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.6;298 K;Ionic strength (raw mmCIF value) 0.055;Pressure 1
NMR sample composition
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR sample composition
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 100% D2O | 100% D2O
NMR sample composition
1.1 mM Human WIP (165-183), 0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 20 mM potassium phosphate, 20 mM sodium chloride, 1 mM dithiothreitol, 0.02 % sodium azide, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR sample composition
1.1 mM Human WIP (165-183), 0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 20 mM potassium phosphate, 20 mM sodium chloride, 1 mM dithiothreitol, 0.02 % sodium azide, 100% D2O | 100% D2O
NMR sample composition
1.1 mM Human WIP (165-183), 0.22 mM [U-99% 13C; U-99% 15N] Human cortactin SH3 domain (494-550), 20 mM potassium phosphate, 20 mM sodium chloride, 1 mM dithiothreitol, 0.02 % sodium azide, 100% D2O | 100% D2O
|
Resolution not provided
|